Physician profile
Travis Dum
NPI 1578829958
$2,459.10
in general payments reported to CMS, 2019-2025
21 companies · $923 in 2025
The $923 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $136 · 2021: $34.93 · 2022: $105 · 2023: $169 · 2024: $318 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.29 |
| Travel and Lodging | $297.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $928.00 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $318.41 | 2019-2025 | Ams 700 |
| Astellas Pharma US INC | $293.27 | 2019-2022 | |
| Neotract INC. | $276.14 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $137.65 | 2023-2025 | Orgovyx, Gemtesa |
| Endo Pharmaceuticals INC. | $83.14 | 2019-2024 | Xiaflex, Aveed, Edex |
| Progenics Pharmaceuticals, INC. | $61.22 | 2022-2025 | Pylarify |
| Abbvie INC. | $37.86 | 2023 | Botox, Lupron Depot |
| Travere Therapeutics, INC. | $37.62 | 2019 | |
| Pfizer INC. | $33.59 | 2019-2020 | |
| Blue Earth Diagnostics | $32.88 | 2019 | |
| Antares Pharma, INC. | $31.99 | 2020 | |
| 180 Medical, INC. | $27.47 | 2024 | Gentlecath |
| Urogen Pharma, INC. | $26.84 | 2020 | |
| Myovant Sciences INC. | $26.54 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $23.66 | 2019 | |
| Ferring Pharmaceuticals INC. | $19.71 | 2019 | |
| Mission Pharmacal Company | $17.84 | 2019 | |
| Photocure INC | $16.29 | 2024 | Cysview |
| Allergan, INC. | $14.89 | 2019 | |
| Olympus America INC. | $14.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Dum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.